Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
222.00    0.00 (0.00%)
Bid:
221.00
Ask:
232.00
Spread: 11.00 (4.977%)
Market Cap: £117.21m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

AGM Statement

14 May 2024 07:00

RNS Number : 1588O
Aptitude Software Group PLC
14 May 2024
 

14 May 2024

 

Aptitude Software Group plc

("Aptitude" or the "Group")

AGM Statement

 

Ivan Martin, Chairman of Aptitude, provides the following trading update in advance of the Annual General Meeting to be held at 9:00 a.m. today.

Highlights

· The Board remains confident that the Group's performance for 2024 will be in line with expectations.

· Ongoing organisational change is delivering positive progress across all functions, accelerating Fynapse readiness and delivery, underpinned by our strategic partnerships.

· Fynapse pipeline continues to grow with key opportunities, including new prospects and the migration of existing clients, progressing well.

· New business success across compliance suite and subscription management solutions, with sales of Aptitude Insurance Calculation Engine to a large Canadian insurer and the sale of eSuite to a UK based video production company.

The Fynapse pipeline continues to develop, benefiting from the Group's strategic focus on the opportunity presented by its intelligent finance data management and accounting platform. This is increasingly supported by the joint go-to-market approach and commitment of key partners to the vision of AI Autonomous Finance.

Despite the ongoing elongated sales cycles caused by current macroeconomic conditions, the Group has continued to achieve new business success in the year to date and is targeting further opportunities to close in H1.

The Group remains focused on the mitigation of client churn on its portfolio of products, with progress made in this area, driven by increased investment in client service and support. The Group does expect some planned client reductions within Assure in the half year.

In line with the continuing organisation change programme, expected to be completed across 2024, the Group continues to carefully manage its cost base, with a view to driving increased operating efficiency. Targeted cost reductions have been undertaken in 2024, while continuing to fund strategic investment to support the organic growth of the business.

The Board remains confident that the Group's performance for 2024 will be in line with expectations and that the ongoing work across the business continues to position Aptitude well to capitalise on the significant growth opportunity presented by Fynapse.

Aptitude Software Group plc

Ivan Martin, Chairman 020-3687-3200

Alex Curran, Chief Executive Officer

Mike Johns, Chief Financial Officer

Alma Strategic Communications

Caroline Forde / Hilary Buchanan 020-3405-0205

About Aptitude Software

Aptitude Software provides software solutions that deliver fully autonomous finance to enable its clients to drive growth, efficiency and sustainability. Fynapse is Aptitude's intelligent finance data management and accounting platform designed to increase productivity and lower costs for finance teams globally. Fynapse provides a single view of finance and business data, unparalleled performance and automation, faster and better insights, user-friendly functionality and market-leading total cost of ownership.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMUOSWRSBUVARR
Date   Source Headline
24th Mar 201112:22 pmRNSAnnual Information Update
2nd Mar 201110:11 amRNSHolding(s) in Company
28th Feb 201110:15 amRNSTotal Voting Rights
25th Feb 201111:53 amRNSDirector/PDMR Shareholding
24th Feb 20117:00 amRNSFinal Results
16th Feb 20113:18 pmRNSNotice of Results
3rd Feb 20115:00 pmRNSHolding(s) in Company
3rd Feb 20114:58 pmRNSHolding(s) in Company
28th Jan 201112:59 pmRNSHolding(s) in Company
17th Jan 20114:18 pmRNSDirector Declaration
14th Jan 20114:18 pmRNSHolding(s) in Company
10th Jan 20117:00 amRNSPre-close Trading Update
7th Jan 201111:49 amRNSBlocklisting Return
7th Jan 201111:48 amRNSBlocklisting Return
4th Jan 201110:10 amRNSTotal Voting Rights
4th Nov 20107:00 amRNSDirector/PDMR Shareholding
3rd Nov 20103:40 pmRNSHolding(s) in Company
29th Oct 201010:00 amRNSTotal Voting Rights
26th Oct 20107:00 amRNSInterim Management Statement
26th Oct 20107:00 amRNSInterim Management Statement
30th Sep 20107:00 amRNSTotal Voting Rights
29th Sep 20108:05 amRNSDirector/PDMR Shareholding
27th Sep 20107:01 amRNSBlocklisting Interim Review
23rd Sep 201010:59 amRNSApplication for Blocklisting
15th Sep 20107:00 amRNSMicrogen Aptitude Modules Launch
9th Sep 20102:37 pmRNSHolding(s) in Company
6th Sep 201012:38 pmRNSHolding(s) in Company
2nd Sep 20104:32 pmRNSHolding(s) in Company
31st Aug 20101:19 pmRNSTotal Voting Rights
23rd Aug 20102:12 pmRNSDirector/PDMR Shareholding
23rd Aug 20107:00 amRNSResult of Tender Offer
19th Aug 201010:09 amRNSGM Announcement
11th Aug 201011:16 amRNSHolding(s) in Company
2nd Aug 20101:15 pmRNSPosting of Shareholder Circular
26th Jul 201012:49 pmRNSHolding(s) in Company
22nd Jul 20107:00 amRNSInterim Results
14th Jul 20103:30 pmRNSNotice of Results
1st Jul 201012:51 pmRNSBlocklisting Interim Review
1st Jul 201012:46 pmRNSBlocklisting Interim Review
24th Jun 20104:35 pmRNSDirector/PDMR Shareholding
3rd Jun 20104:38 pmRNSHolding(s) in Company
1st Jun 20102:14 pmRNSDirector Declaration
4th May 20109:57 amRNSTotal Voting Rights
27th Apr 201012:26 pmRNSDirector/PDMR Shareholding
23rd Apr 20102:41 pmRNSDirector/PDMR Shareholding
22nd Apr 20107:00 amRNSInterim Management Statement
16th Apr 20101:56 pmRNSDirector Declaration
22nd Mar 201010:03 amRNSAGM Statement
18th Mar 201011:33 amRNSAnnual Information Update
16th Mar 20105:36 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.